ARROWSTREET CAPITAL, LIMITED PARTNERSHIP - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,047 filers reported holding BAXTER INTL INC in Q4 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ownership history of BAXTER INTL INC
ValueSharesWeighting
Q2 2023$15,113
-72.8%
331,707
-75.7%
0.02%
-75.0%
Q1 2023$55,465
+6.3%
1,367,492
+33.6%
0.07%
-1.4%
Q4 2022$52,182
-99.9%
1,023,788
+15.2%
0.07%
+2.8%
Q3 2022$47,873,000
-63.4%
888,845
-56.4%
0.07%
-61.6%
Q2 2022$130,902,000
-36.9%
2,038,019
-23.8%
0.18%
-28.6%
Q1 2022$207,357,000
+52.1%
2,674,196
+68.4%
0.26%
+55.1%
Q4 2021$136,346,000
+10.2%
1,588,376
+3.2%
0.17%
+7.7%
Q3 2021$123,764,000
-35.5%
1,538,773
-35.5%
0.16%
-34.3%
Q2 2021$192,008,000
-26.4%
2,385,189
-22.9%
0.24%
-32.4%
Q1 2021$260,954,000
+29.6%
3,094,077
+23.3%
0.35%
+22.9%
Q4 2020$201,323,000
+55.8%
2,509,014
+56.1%
0.28%
+38.5%
Q3 2020$129,258,000
+24.3%
1,607,281
+33.1%
0.20%
+7.3%
Q2 2020$103,993,000
+141.4%
1,207,814
+127.6%
0.19%
+57.9%
Q1 2020$43,088,000
+4195.9%
530,706
+4322.6%
0.12%
+5950.0%
Q4 2019$1,003,000
-64.1%
12,000
-66.9%
0.00%
-66.7%
Q3 2018$2,791,000
+96.8%
36,200
+88.5%
0.01%
+100.0%
Q2 2018$1,418,000
-55.2%
19,200
-60.6%
0.00%
-57.1%
Q1 2018$3,167,000
-73.7%
48,700
-74.6%
0.01%
-78.1%
Q3 2017$12,029,000
-91.8%
191,701
-92.1%
0.03%
-92.8%
Q2 2017$146,663,000
+117.2%
2,422,575
+86.0%
0.44%
+79.0%
Q1 2017$67,532,0001,302,1940.25%
Other shareholders
BAXTER INTL INC shareholders Q4 2018
NameSharesValueWeighting ↓
Tri Locum Partners LP 298,721$23,969,0008.70%
GENERATION INVESTMENT MANAGEMENT LLP 17,424,560$1,398,147,0006.24%
Soditic Asset Management LLP 77,950$6,255,0006.24%
Veritas Asset Management LLP 11,110,132$891,477,0005.32%
Dash Acquisitions Inc. 84,560$6,785,0004.74%
Prosight Management, LP 121,075$9,715,0004.49%
TSFG, LLC 94,977$7,621,0004.07%
CINCINNATI FINANCIAL CORP 1,344,648$107,895,0002.93%
Dundas Partners LLP 204,535$19,304,0002.82%
Unified Trust Company, N.A. 59,491$4,689,0002.72%
View complete list of BAXTER INTL INC shareholders